A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, finding the companies sometimes increased prices of these drugs by 1,000 ...
The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
This policy guidance provides recommendations for items that are available over the counter (OTC) and should not be routinely prescribed in primary care because: there is limited evidence of clinical ...